- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05412264
Step Up For Health Study: A Pedometer and Website Intervention in Those With Prediabetes
Step Up for Health: A Pedometer-based Randomized Controlled Trial for Individuals at High Risk for Type 2 Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Relevance to diabetes: Without intervention, most people at high-risk of diabetes (e.g., with prediabetes) will eventually develop type 2 diabetes over time. Moderate physical activity of 150 minutes per week has been demonstrated to improve glucose tolerance and decrease type 2 diabetes risk. Research is needed to determine the effectiveness and acceptability of web-based methods of increasing physical activity, specifically walking, in these high risk populations.
Brief background of the issue: Studies completed in adults with prediabetes have demonstrated lower physical activity levels than the general population; however, adults with prediabetes have reported they are interested in a physical activity program that is focused on individuals with prediabetes.
Objective: To determine if a theoretically-based physical activity internet website with pedometer step and physical activity monitoring is able to increase physical activity behavior among adults at high risk of type 2 diabetes.
Hypothesis: Individuals at high risk of type 2 diabetes randomized to the intervention group will increase their pedometer steps and physical activity over a 12-week intervention compared to individuals in the control group.
Methods: Four hundred adults at high risk of type 2 diabetes will be recruited from the Edmonton and Calgary prediabetes education classes by Registered Dietitians (RD) teaching the class. The RD will discuss the study and interested participants will receive a pedometer, waist circumference tape and study information letter at the class. In the study information letter they will be directed to a website where they can agree to participate in the study after completing a brief questionnaire to determine study eligibility and a Physical activity readiness (e-ParMedX) form to determine physical activity safety. After completing these documents, if they are eligible to participate they will complete an online baseline questionnaire, a 3-day pedometer step test and a waist circumference measurement. All measurements and personal information will be recorded on the secure website. These measurements will be repeated at 12 weeks and 16 weeks post intervention. Upon completion of the baseline measures, they will be randomized by the website program into either the control or intervention group. The intervention group will receive a theoretically-based 12-week intervention program via the website designed to increase their physical activity and steps. The website content is based on the theory of planned behaviour and tailored to people at high-risk of type 2 diabetes. Participants will receive weekly information that is temporally sequenced on the website for each of the 12 weeks, set weekly goals and record their daily steps on the website. After the control group has completed their six-month assessment they will also be able to access the 12 week intervention.
Application to Practice: If able to successfully increase physical activity, this trial will identify a theoretically-based web and home-based intervention that can be offered to individuals who participate in lifestyle programs delivered in primary care settings (e.g., Edmonton prediabetes program) in both rural and urban locations. Research is needed to determine the effectiveness and acceptability of web-based methods of increasing physical activity, specifically walking, in these high-risk populations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T1B 0E1
- Alberta Health Services, Nutrition Services
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- You are over 18 years of age.
- Have been told you have prediabetes by a health professional.
- You are free from any medical problems that make it hard to be active. For example, congestive heart failure, a recent knee or hip replacement, or you need to use a cane or walker to help you walk.
- Live in Alberta.
- Are interested in finding ways to become more physically active.
- Are interested in wearing a pedometer and tracking your daily steps.
Exclusion Criteria:
- You have been told you have type 2 diabetes.
- You do not confirm on the website that it is safe for you to increase your walking or other physical activities.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Website intervention
Website access: 12 Weekly emails, access to website with goal setting and recording steps
|
12 week motivational emails, recording pedometer steps and waist circumference
|
|
No Intervention: Delayed access
Will not receive access to the program/website until they complete their 16 week assessments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Increased pedometer steps
Time Frame: 12 weeks
|
Measured as a 3-day step test
|
12 weeks
|
|
Increased pedometer steps
Time Frame: 16 weeks
|
Measured as a 3-day step test
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist circumference
Time Frame: 12 weeks
|
Measured
|
12 weeks
|
|
Waist circumference
Time Frame: 16 weeks
|
Measured
|
16 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire
Time Frame: 12 weeks
|
Measuring changes in attitude, social norms and perceived behavioral control
|
12 weeks
|
|
Questionnaire
Time Frame: 16 weeks
|
Measuring changes in attitude, social norms and perceived behavioral control
|
16 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeffrey Vallance, PhD, Athabasca University
- Principal Investigator: Lorian Taylor, PhD, Alberta Health Services
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00039828
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impaired Glucose Tolerance
-
Psychiatric Centre RigshospitaletUniversity of Cambridge; University Hospital, Gentofte, CopenhagenUnknownImpaired Glucose Tolerance Associated With DrugsDenmark
-
Maastricht University Medical CenterCompletedObesity | Insulin Resistance | Impaired Glucose Tolerance in ObeseNetherlands
-
Columbia UniversityCompletedBody Weight | Impaired Glucose Tolerance in ObeseUnited States
-
The University of Texas Health Science Center at...Amylin Pharmaceuticals, LLC.CompletedDiabetes | Impaired Glucose Tolerance (IGT)United States
-
Wroclaw Medical UniversityCompletedPreDiabetes | Impaired Glucose Tolerance (IGT) | Impaired Fasting Glucose (IFG)Poland
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedT2D | IGT - Impaired Glucose ToleranceUnited States
-
University of Oslo School of PharmacyCompletedRenal Transplant Recipients | Posttransplant Diabetes Mellitus | Posttransplant Impaired Glucose ToleranceNorway
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); A... and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Impaired Glucose Tolerance (IGT) | Impaired Fasting Glucose (IFG)United States
-
Jean L. FryCompletedPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)United States
Clinical Trials on Website intervention
-
Northwestern UniversityNational Cancer Institute (NCI); Georgetown University; Hackensack Meridian HealthRecruitingLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Stem Cell Transplant | Hematologic Malignancy | Bone Marrow TransplantUnited States
-
Northwestern UniversityCompletedEnd Stage Kidney DiseaseUnited States
-
The Policy & Research GroupDepartment of Health and Human ServicesActive, not recruiting
-
University of BathCompletedOverweight/ObesityUnited Kingdom
-
East Carolina UniversityBoston University; University of HoustonCompleted
-
Case Western Reserve UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHealth Behavior | Organ DonationUnited States
-
University of California, San FranciscoCompletedProstate CancerUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA)SuspendedElder Abuse | Caregiver Wellbeing | Caregivers of Alzheimer's Disease or Memory Problem PatientsUnited States
-
Northwestern UniversityWithdrawnIndividuals at Risk for DepressionUnited States
-
Brown UniversityCenters for Disease Control and PreventionUnknownHIV InfectionsUnited States